| Literature DB >> 25054318 |
Wei-Xin Liu1, En-Ze Deng2, Wei Chen3, Hao Lin4.
Abstract
Voltage-gated K+ channel (VKC) plays important roles in biology procession, especially in nervous system. Different subfamilies of VKCs have different biological functions. Thus, knowing VKCs' subfamilies has become a meaningful job because it can guide the direction for the disease diagnosis and drug design. However, the traditional wet-experimental methods were costly and time-consuming. It is highly desirable to develop an effective and powerful computational tool for identifying different subfamilies of VKCs. In this study, a predictor, called iVKC-OTC, has been developed by incorporating the optimized tripeptide composition (OTC) generated by feature selection technique into the general form of pseudo-amino acid composition to identify six subfamilies of VKCs. One of the remarkable advantages of introducing the optimized tripeptide composition is being able to avoid the notorious dimension disaster or over fitting problems in statistical predictions. It was observed on a benchmark dataset, by using a jackknife test, that the overall accuracy achieved by iVKC-OTC reaches to 96.77% in identifying the six subfamilies of VKCs, indicating that the new predictor is promising or at least may become a complementary tool to the existing methods in this area. It has not escaped our notice that the optimized tripeptide composition can also be used to investigate other protein classification problems.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25054318 PMCID: PMC4139883 DOI: 10.3390/ijms150712940
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Schematic representation of potassium (K+) channel subunit. The S1, S2, S3, S4, S5, S6 are six transmembrane helices.
Breakdown of the 217 voltage-gated K+ channels (VKCs) in the benchmark dataset S according to their six subfamilies.
| Dataset | Channel Subfamilies | Number of VKC Samples |
|---|---|---|
| S1 | Kv1 | 82 |
| S2 | Kv2 | 16 |
| S3 | Kv3 | 37 |
| S4 | Kv4 | 32 |
| S5 | Kv6 | 10 |
| S6 | Kv7 | 40 |
| S | Overall | 217 |
Figure 2The IFS curve (red) in a 3D Cartesian coordinate system for predicting six subfamilies of VKCs. The blue, green and yellow lines are the projections of the IFS curve on the Overall accuracy/Confidence level plane, the Overall accuracy/Feature dimension plane, the Feature dimension/Confidence level plane, respectively.
Comparison with other published methods.
| Family | This Paper | SVM [
| Naïve Bayes [
| Random Forest [
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||||||
| Kv1 | 100.00 | 96.30 | 0.95 | 93.90 | 93.98 | 0.86 | 93.90 | 83.85 | 0.76 | 97.56 | 78.51 | 0.76 |
| Kv2 | 93.75 | 100.00 | 0.96 | 87.50 | 98.95 | 0.86 | 81.25 | 100.00 | 0.89 | 75.00 | 98.78 | 0.82 |
| Kv3 | 97.30 | 98.89 | 0.95 | 89.19 | 97.69 | 0.87 | 81.08 | 95.12 | 0.75 | 59.45 | 97.44 | 0.67 |
| Kv4 | 100.00 | 100.00 | 1.00 | 93.75 | 100.00 | 0.96 | 87.50 | 100.00 | 0.92 | 65.38 | 98.73 | 0.75 |
| Kv6 | 80.00 | 100.00 | 0.89 | 100.00 | 100.00 | 1.00 | 40.00 | 100.00 | 0.62 | 80.00 | 98.82 | 0.87 |
| Kv7 | 92.50 | 100.00 | 0.95 | 95.00 | 99.39 | 0.95 | 85.00 | 98.70 | 0.87 | 85.00 | 99.29 | 0.89 |
| Average | 93.92 | 93.22 | 78.12 | 77.07 | ||||||||
| Average | 99.20 | 98.34 | 96.28 | 95.26 | ||||||||
| 96.77 | 93.09 | 85.71 | 82.03 | |||||||||
Comparison with different methods on training set.
| Method | Sn (%) | OA (%) | |||||
|---|---|---|---|---|---|---|---|
| Kv1 | Kv2 | Kv3 | Kv4 | Kv6 | Kv7 | ||
| Optimal tripeptides (Our method) | 100.00 | 93.75 | 97.30 | 100.00 | 80.00 | 92.50 | 96.77 |
| Optimal tripeptides (SVM-RFE) | 100.00 | 81.25 | 91.67 | 96.88 | 80.00 | 87.55 | 93.09 |
| Traditional PseAAC | 82.93 | 81.25 | 72.97 | 78.13 | 80.00 | 87.50 | 81.11 |
| Optimal tripeptides (Our method) + PseAAC | 100.00 | 87.50 | 97.30 | 100.00 | 80.00 | 92.50 | 96.31 |
| Optimal tripeptides (Our method) + Dipeptides | 100.00 | 81.25 | 94.59 | 100.00 | 80.00 | 92.50 | 95.39 |
Figure 3A semi-screenshot for the top page of the iVKC-OTC.